ArisGlobal Massachusetts United States of America United Kingdom Florida Germany England

New Momentum in Pharma Automation: ArisGlobal's 2024 Industry Survey Report Highlights Surge in AI-Powered Safety & Regulatory Processes

The pace of companies' transitions to intelligent automation is accelerating: 60% are looking to explore new usage or increase their usage of advanced technologies over the next 18 months.Today, while more than 75% of organizations claim they now already use "some" form of advanced automation (harnessing AI/machine learning), only 8% have applied next-gen capabilities in "all" or "most" processes. Overcoming integration challenges will be key to new progress, which from a Safety perspective for many companies is linked to being able to harness reliable Real-World Data.View original content:https://www.prnewswire.co.uk/news-releases/new-momentum-in-pharma-automation-arisglobals-2024-industry-survey-report-highlights-surge-in-ai-powered-safety--regulatory-processes-302139767.html